ロード中...
Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses
INTRODUCTION: Dolutegravir is a second generation integrase inhibitor with a proposed high genetic barrier to resistance. However, in clinical trials, decreased virological response was seen in a subset of patients with prior exposure to raltegravir and multiple integrase resistance mutations. METHO...
保存先:
| 出版年: | J Int AIDS Soc |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International AIDS Society
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225339/ https://ncbi.nlm.nih.gov/pubmed/25397500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19755 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|